And Clinically Tested
The sports nutrition recovery solution with clinically-proven results
Viscos, LLC is dedicated to meeting and exceeding nutraceutical industry standards through continuing clinical research initiatives.
Viscos first implemented its research program with a randomized, double-blind placebo-controlled clinical study to establish the safety and efficacy of its formula. That study, “Oral Intake of a Liquid High-Molecular-Weight Hyaluronan Associated with Relief of Chronic Pain and Reduced Use of Pain Medication: Results of a Randomized, Placebo-Controlled Double-Blind Pilot Study,”* was published in the peer-reviewed Journal of Medicinal Food in January 2015. Results from the four-week pilot study included:
- Decreased pain
- Reduced use of pain medication
- Improved sleep quality
- Overall safety well within normal parameters
The next research initiative extended the four-week clinical study into a year-long open-label study to confirm continuing safety and efficacy at the one-year mark: “Evaluation of effects of consumption of Play Again on chronic pain and functionality: Results from a 1-year open-label clinical study.” The data showed a steady decrease in pain and use of medication throughout the one-year study. By the end of the one-year study, a highly significant reduction in chronic pain was seen in the study participants.
Subsequently, a direct extension from the previous 4-week and 1-year studies was conducted, in order to verify the effectiveness of the new Play Again Now® formulation with the addition of MSM. The many improvements in this open label study (“Evaluation of effects of consumption of Play Again Now® on chronic pain in humans: An open-label feasibility study”) reached statistical significance already at two weeks, and continued to improve at four weeks. Improvements went beyond simple pain reduction, and significantly altered physical functioning and quality of life.
Viscos is engaged in continuing research and has additional completed study data on file. For additional information, contact email@example.com.
*”Oral Intake of a Liquid High-Molecular-Weight Hyaluronan Associated with Relief of Chronic Pain and Reduced Use of Pain Medication: Results of a Randomized, Placebo-Controlled Double-Blind Pilot Study,” Gitte S. Jensen, Victoria L. Attridge, Miki R. Lenninger, and Kathleen F. Benson. Journal of Medicinal Food 18 (1) 2015, 95–101.